Log in
NASDAQ:IRTC

Irhythm Technologies Stock Forecast, Price & News

$222.54
+4.74 (+2.18 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$214.59
Now: $222.54
$224.25
50-Day Range
$172.95
MA: $207.34
$233.33
52-Week Range
$56.24
Now: $222.54
$241.82
Volume167,265 shs
Average Volume396,826 shs
Market Capitalization$6.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.8
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. Its Zio XT monitor, a single-use, wire-free, and wearable patch-based biosensor, records patient's heartbeats and ECG data. The company was founded in 2006 and is headquartered in San Francisco, California.
Read More
Irhythm Technologies logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.19 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:IRTC
CUSIPN/A
Phone415-632-5700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$214.55 million
Book Value$5.09 per share

Profitability

Net Income$-54,570,000.00

Miscellaneous

Employees748
Market Cap$6.10 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$222.54
+4.74 (+2.18 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Irhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

How has Irhythm Technologies' stock been impacted by Coronavirus?

Irhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IRTC stock has increased by 160.2% and is now trading at $222.54.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Irhythm Technologies?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Irhythm Technologies
.

When is Irhythm Technologies' next earnings date?

Irhythm Technologies is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Irhythm Technologies
.

How were Irhythm Technologies' earnings last quarter?

Irhythm Technologies Inc (NASDAQ:IRTC) posted its quarterly earnings results on Thursday, August, 6th. The company reported ($0.75) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.84) by $0.09. The company earned $50.88 million during the quarter, compared to the consensus estimate of $42.18 million. Irhythm Technologies had a negative net margin of 28.50% and a negative return on equity of 50.23%. The firm's revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the previous year, the business earned ($0.43) EPS.
View Irhythm Technologies' earnings history
.

What price target have analysts set for IRTC?

12 analysts have issued 1-year price objectives for Irhythm Technologies' stock. Their forecasts range from $130.00 to $250.00. On average, they anticipate Irhythm Technologies' stock price to reach $183.11 in the next year. This suggests that the stock has a possible downside of 17.7%.
View analysts' price targets for Irhythm Technologies
.

Are investors shorting Irhythm Technologies?

Irhythm Technologies saw a drop in short interest during the month of August. As of August 14th, there was short interest totaling 3,040,000 shares, a drop of 20.0% from the July 30th total of 3,800,000 shares. Based on an average daily volume of 420,200 shares, the short-interest ratio is currently 7.2 days.
View Irhythm Technologies' Short Interest
.

Who are some of Irhythm Technologies' key competitors?

What other stocks do shareholders of Irhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include NVIDIA (NVDA), salesforce.com (CRM), Trade Desk (TTD), Alibaba Group (BABA), Square (SQ), Teladoc Health (TDOC), DexCom (DXCM), Advanced Micro Devices (AMD), Boeing (BA) and Cisco Systems (CSCO).

Who are Irhythm Technologies' key executives?

Irhythm Technologies' management team includes the following people:
  • Mr. Kevin M. King, Pres, CEO & Director (Age 63)
  • Mr. Matthew C. Garrett, Chief Financial Officer (Age 51)
  • Mr. David A. Vort, Exec. VP of Sales (Age 53)
  • Dr. Derrick Sung, Exec. VP of Strategy & Corp. Devel. (Age 46)
  • Mr. Karim Karti, Chief Operating Officer (Age 50)

When did Irhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is Irhythm Technologies' stock symbol?

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are Irhythm Technologies' major shareholders?

Irhythm Technologies' stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.26%), William Blair Investment Management LLC (5.27%), Macquarie Group Ltd. (3.22%), Neuberger Berman Group LLC (2.79%), TimesSquare Capital Management LLC (2.27%) and New York State Common Retirement Fund (2.02%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for Irhythm Technologies
.

Which institutional investors are selling Irhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Holocene Advisors LP, Bank of New York Mellon Corp, Macquarie Group Ltd., TimesSquare Capital Management LLC, Bellevue Group AG, Sei Investments Co., Great Lakes Advisors LLC, and Principal Financial Group Inc.. Company insiders that have sold Irhythm Technologies company stock in the last year include David A Vort, Kevin M King, Matthew C Garrett, Ralph Snyderman, and Raymond W Scott.
View insider buying and selling activity for Irhythm Technologies
.

Which institutional investors are buying Irhythm Technologies stock?

IRTC stock was acquired by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, FMR LLC, Blair William & Co. IL, Man Group plc, Columbus Circle Investors, Vanguard Group Inc., Federated Hermes Inc., and First Trust Advisors LP.
View insider buying and selling activity for Irhythm Technologies
.

How do I buy shares of Irhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Irhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $222.54.

How big of a company is Irhythm Technologies?

Irhythm Technologies has a market capitalization of $6.10 billion and generates $214.55 million in revenue each year. The company earns $-54,570,000.00 in net income (profit) each year or ($2.16) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.

What is Irhythm Technologies' official website?

The official website for Irhythm Technologies is www.irhythmtech.com.

How can I contact Irhythm Technologies?

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.